<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02137499</url>
  </required_header>
  <id_info>
    <org_study_id>13/WM/0027</org_study_id>
    <secondary_id>CR02072</secondary_id>
    <nct_id>NCT02137499</nct_id>
  </id_info>
  <brief_title>Venous Insufficiency and Neuromuscular Stimulation</brief_title>
  <acronym>VeINS</acronym>
  <official_title>Venous Insufficiency and Neuromuscular Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will be evaluating the immediate and longer term effect of treatment with a
      medical device on the symptoms of chronic venous disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      STUDY AIMS

        1. To obtain ultrasound blood flow and velocity measurements in the leg to compare the
           hemodynamic profiles obtained using a neuromuscular stimulation device with those
           obtained at rest.

        2. To ascertain if a 6 week protocol of electrical neurostimulation of the muscle pumps in
           the leg and foot can reduce clinical symptoms and improve quality of life.

      METHODS Controlled interventional trial. Group 1 (10 subjects) will be healthy subjects with
      no clinical venous disease. Subjects with venous incompetence to be recruited into one of
      three groups. Group 2 (10 subjects) will have superficial venous incompetence; Group 3 (10
      subjects) will have deep venous incompetence; Group 4 (10 subjects) will have deep vein
      occlusion. These will be clinical diagnoses confirmed with duplex ultrasound.

      The device used in this study will be the geko™ T-1 device (Firstkind Ltd, UK). A geko™
      device will be fitted to each leg. The device stimulation level is set to the minimum level
      that can achieve the desired response (outward and upward twitching of the foot when raised
      from the ground).

      ENDPOINTS Primary end-point

        -  Increase in venous flow Secondary end points

        -  Improvement in clinical symptoms at 6 weeks, as judged by questionnaire

        -  Reduction in absolute leg diameter and volume at 6 weeks
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2013</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage Change of Haemodynamic Flow</measure>
    <time_frame>baseline, 20 minutes</time_frame>
    <description>Doppler ultrasound measurements of femoral venous blood flow. The volume flow rate in blood vessel can be calculated by multiplying the cross-sectional area of the blood vessel by the mean velocity of the blood within it.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in Venous Symptoms</measure>
    <time_frame>6 weeks</time_frame>
    <description>Clinical symptoms will be measured using questionnaires (AVVQ, VCSS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leg Volume</measure>
    <time_frame>6 weeks</time_frame>
    <description>Measured using ankle and calf circumference, and multiplying using &quot;inverted cone&quot; method</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Chronic Venous Disease</condition>
  <condition>Venous Insufficiency</condition>
  <condition>Deep Venous Obstruction</condition>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy subjects, free from vascular disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Superficial venous insufficiency</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinically symptomatic and ultrasound evidence of superficial venous insufficiency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deep venous insufficiency</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinically symptomatic and ultrasound evidence of deep venous insufficiency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deep venous obstruction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinically symptomatic and ultrasound evidence of deep venous obstruction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>geko device</intervention_name>
    <description>Small transcutaneous electrical stimulator. Manufactured in UK by Firstkind UK Ltd, and licensed for use in humans</description>
    <arm_group_label>Deep venous insufficiency</arm_group_label>
    <arm_group_label>Deep venous obstruction</arm_group_label>
    <arm_group_label>Healthy subjects</arm_group_label>
    <arm_group_label>Superficial venous insufficiency</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Group 1

          -  Inclusion criteria - 18+ years old, 17&lt;BMI&lt;30

          -  Exclusion criteria - Heart/lung/kidney failure, pregnancy, diagnosis of peripheral
             vascular disease, previous VTE, ABPI&lt;0.9, active infection, previous leg fracture or
             metal implant in leg

        Group 2

          -  Inclusion criteria - 18+ years old, 17&lt;BMI&lt;30, clinical diagnosis of superficial
             venous insufficiency (CEAP C2-6) confirmed with duplex US

          -  Exclusion criteria - Heart/lung/kidney failure, pregnancy, ABPI&lt;0.9, active infection,
             previous leg fracture or metal implant in leg

        Group 3

          -  Inclusion criteria - 18+ years old, 17&lt;BMI&lt;30, clinical diagnosis of deep venous
             insufficiency (CEAP C2-6) confirmed with duplex US

          -  Exclusion criteria - Heart/lung/kidney failure, pregnancy, ABPI&lt;0.9, active infection,
             previous leg fracture or metal implant in leg

        Group 4

          -  Inclusion criteria - 18+ years old, 17&lt;BMI&lt;30, clinical diagnosis of deep venous
             obstruction confirmed with duplex US

          -  Exclusion criteria - Heart/lung/kidney failure, pregnancy, ABPI&lt;0.9, active infection,
             previous leg fracture or metal implant in leg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alun Davies</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charing Cross Hospital</name>
      <address>
        <city>Hammersmith</city>
        <state>London</state>
        <zip>W6 8RF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>May 12, 2014</study_first_submitted>
  <study_first_submitted_qc>May 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2014</study_first_posted>
  <results_first_submitted>September 18, 2019</results_first_submitted>
  <results_first_submitted_qc>September 18, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 11, 2019</results_first_posted>
  <last_update_submitted>October 11, 2019</last_update_submitted>
  <last_update_submitted_qc>October 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Deep venous obstruction</keyword>
  <keyword>Venous insufficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Venous Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Healthy Subjects</title>
          <description>Healthy participants treated with Small transcutaneous electrical stimulator</description>
        </group>
        <group group_id="P2">
          <title>Superficial Venous Insufficiency</title>
          <description>Participants with Superficial venous insufficiency treated with Small transcutaneous electrical stimulator</description>
        </group>
        <group group_id="P3">
          <title>Deep Venous Insufficiency</title>
          <description>Participant with Deep venous insufficiency treated with Small transcutaneous electrical stimulator</description>
        </group>
        <group group_id="P4">
          <title>Deep Venous Obstruction</title>
          <description>Participant with Deep venous obstruction treated with Small transcutaneous electrical stimulator</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Healthy Subjects</title>
          <description>Healthy participants treated with Small transcutaneous electrical stimulator</description>
        </group>
        <group group_id="B2">
          <title>Superficial Venous Insufficiency</title>
          <description>Participants with Superficial venous insufficiency treated with Small transcutaneous electrical stimulator</description>
        </group>
        <group group_id="B3">
          <title>Deep Venous Insufficiency</title>
          <description>Participants with Deep venous insufficiency treated with Small transcutaneous electrical stimulator</description>
        </group>
        <group group_id="B4">
          <title>Deep Venous Obstruction</title>
          <description>Participants with Deep venous obstruction treated with Small transcutaneous electrical stimulator</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="10"/>
            <count group_id="B4" value="10"/>
            <count group_id="B5" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="10"/>
                    <count group_id="B4" value="10"/>
                    <count group_id="B5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.7" spread="10"/>
                    <measurement group_id="B2" value="55" spread="15"/>
                    <measurement group_id="B3" value="58.6" spread="18"/>
                    <measurement group_id="B4" value="53.2" spread="16"/>
                    <measurement group_id="B5" value="56" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="10"/>
                    <count group_id="B4" value="10"/>
                    <count group_id="B5" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage Change of Haemodynamic Flow</title>
        <description>Doppler ultrasound measurements of femoral venous blood flow. The volume flow rate in blood vessel can be calculated by multiplying the cross-sectional area of the blood vessel by the mean velocity of the blood within it.</description>
        <time_frame>baseline, 20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Subjects</title>
            <description>Healthy participants treated with Small transcutaneous electrical stimulator</description>
          </group>
          <group group_id="O2">
            <title>Superficial Venous Insufficiency</title>
            <description>Participants with Superficial venous insufficiency treated with Small transcutaneous electrical stimulator</description>
          </group>
          <group group_id="O3">
            <title>Deep Venous Insufficiency</title>
            <description>Participants with Deep venous insufficiency treated with Small transcutaneous electrical stimulator</description>
          </group>
          <group group_id="O4">
            <title>Deep Venous Obstruction</title>
            <description>Participants with Deep venous obstruction treated with Small transcutaneous electrical stimulator</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Change of Haemodynamic Flow</title>
          <description>Doppler ultrasound measurements of femoral venous blood flow. The volume flow rate in blood vessel can be calculated by multiplying the cross-sectional area of the blood vessel by the mean velocity of the blood within it.</description>
          <units>% change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Peak velocity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.8" lower_limit="-4" upper_limit="81"/>
                    <measurement group_id="O2" value="62.8" lower_limit="25" upper_limit="138"/>
                    <measurement group_id="O3" value="9" lower_limit="-10" upper_limit="84"/>
                    <measurement group_id="O4" value="14.8" lower_limit="-8" upper_limit="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TAMV time-averaged mean velocity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-14.2" lower_limit="-30" upper_limit="55"/>
                    <measurement group_id="O2" value="28.1" lower_limit="-2" upper_limit="111"/>
                    <measurement group_id="O3" value="28.2" lower_limit="-30" upper_limit="66"/>
                    <measurement group_id="O4" value="-5.1" lower_limit="-28" upper_limit="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Volume flow</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-22.5" lower_limit="-40" upper_limit="40"/>
                    <measurement group_id="O2" value="37.5" lower_limit="-10" upper_limit="172"/>
                    <measurement group_id="O3" value="17.4" lower_limit="1" upper_limit="49"/>
                    <measurement group_id="O4" value="5.9" lower_limit="-11" upper_limit="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Improvement in Venous Symptoms</title>
        <description>Clinical symptoms will be measured using questionnaires (AVVQ, VCSS)</description>
        <time_frame>6 weeks</time_frame>
        <population>Data not collected</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Subjects</title>
            <description>Healthy participants treated with Small transcutaneous electrical stimulator</description>
          </group>
          <group group_id="O2">
            <title>Superficial Venous Insufficiency</title>
            <description>Participants with Superficial venous insufficiency treated with Small transcutaneous electrical stimulator</description>
          </group>
          <group group_id="O3">
            <title>Deep Venous Insufficiency</title>
            <description>Participants with Deep venous insufficiency treated with Small transcutaneous electrical stimulator</description>
          </group>
          <group group_id="O4">
            <title>Deep Venous Obstruction</title>
            <description>Participants with Deep venous obstruction treated with Small transcutaneous electrical stimulator</description>
          </group>
        </group_list>
        <measure>
          <title>Improvement in Venous Symptoms</title>
          <description>Clinical symptoms will be measured using questionnaires (AVVQ, VCSS)</description>
          <population>Data not collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Leg Volume</title>
        <description>Measured using ankle and calf circumference, and multiplying using &quot;inverted cone&quot; method</description>
        <time_frame>6 weeks</time_frame>
        <population>Data not collected</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Subjects</title>
            <description>Healthy participants treated with Small transcutaneous electrical stimulator</description>
          </group>
          <group group_id="O2">
            <title>Superficial Venous Insufficiency</title>
            <description>Participants with Superficial venous insufficiency treated with Small transcutaneous electrical stimulator</description>
          </group>
          <group group_id="O3">
            <title>Deep Venous Insufficiency</title>
            <description>Participants with Deep venous insufficiency treated with Small transcutaneous electrical stimulator</description>
          </group>
          <group group_id="O4">
            <title>Deep Venous Obstruction</title>
            <description>Participants with Deep venous obstruction treated with Small transcutaneous electrical stimulator</description>
          </group>
        </group_list>
        <measure>
          <title>Leg Volume</title>
          <description>Measured using ankle and calf circumference, and multiplying using &quot;inverted cone&quot; method</description>
          <population>Data not collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>10 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Healthy Subjects</title>
          <description>Healthy participants treated with Small transcutaneous electrical stimulator</description>
        </group>
        <group group_id="E2">
          <title>Superficial Venous Insufficiency</title>
          <description>Participants with Superficial venous insufficiency treated with Small transcutaneous electrical stimulator</description>
        </group>
        <group group_id="E3">
          <title>Deep Venous Insufficiency</title>
          <description>Participants with Deep venous insufficiency treated with Small transcutaneous electrical stimulator</description>
        </group>
        <group group_id="E4">
          <title>Deep Venous Obstruction</title>
          <description>Participants with Deep venous obstruction treated with Small transcutaneous electrical stimulator</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Miss Kate Williams</name_or_title>
      <organization>Imperial College London</organization>
      <email>k.williams@imperial.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

